Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Niger
Niger: Diphtheria tetanus toxoid and pertussis third-dose (DTP3) was 87.0% in 2025. ▲ Rising
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Niger, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Niger is 87.0%, measured in 2025. That is the highest value across all 26 years on record.
Compared with earlier readings it is up 1.2% on the previous year and up 3.6% over ten years.
Over the whole period, diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Niger peaked at 87.0% in 2025 and was at its lowest, 34.0%, in 2000.
Niger ranks 117th of 194 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 26 years of available data.
Diphtheria tetanus toxoid and pertussis third-dose (DTP3) in Niger, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 34.0% | — |
| 2001 | 36.0% | +5.9% |
| 2002 | 39.0% | +8.3% |
| 2003 | 41.0% | +5.1% |
| 2004 | 43.0% | +4.9% |
| 2005 | 45.0% | +4.7% |
| 2006 | 52.0% | +15.6% |
| 2007 | 58.0% | +11.5% |
| 2008 | 67.0% | +15.5% |
| 2009 | 71.0% | +6.0% |
| 2010 | 70.0% | -1.4% |
| 2011 | 75.0% | +7.1% |
| 2012 | 73.0% | -2.7% |
| 2013 | 75.0% | +2.7% |
| 2014 | 82.0% | +9.3% |
| 2015 | 84.0% | +2.4% |
| 2016 | 80.0% | -4.8% |
| 2017 | 85.0% | +6.2% |
| 2018 | 79.0% | -7.1% |
| 2019 | 81.0% | +2.5% |
| 2020 | 81.0% | +0.0% |
| 2021 | 82.0% | +1.2% |
| 2022 | 84.0% | +2.4% |
| 2023 | 85.0% | +1.2% |
| 2024 | 86.0% | +1.2% |
| 2025 | 87.0% | +1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 48.6% | 34.0% | 71.0% | 10 |
| 2010s | 78.4% | 70.0% | 85.0% | 10 |
| 2020s | 84.2% | 81.0% | 87.0% | 6 |
Countries ranked near Niger
- 117 Dominican Republic 87.0% compare
- 117 Sao Tome and Principe 87.0% compare
- 117 Solomon Islands 87.0% compare
- 117 Kiribati 87.0% compare
More health data for Niger
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.35 % change on previous year (2090)
- Heat deaths vs projected death rates 887.5 (2090)
- Un projection of annual infant deaths 22,995 (2100)
- Population ages 65 and above, total, annual growth rate 4.22 % change on previous year (2025)
- Population ages 65 and above, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, total, per capita 0.0262 units per person (2025)
- Population, female, annual growth rate 3.28 % change on previous year (2025)
- Population, female, per unit of GDP 0.0006 units per US$ of GDP (2025)
- Population, female, per capita 0.4923 units per person (2025)
Frequently asked questions
- What is diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Niger?
- Diphtheria tetanus toxoid and pertussis third-dose (dtp3) in Niger was 87.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Niger?
- The highest recorded value was 87.0% in 2025.
- What is the lowest diphtheria tetanus toxoid and pertussis third-dose (dtp3) recorded in Niger?
- The lowest recorded value was 34.0% in 2000.
- How does Niger rank for diphtheria tetanus toxoid and pertussis third-dose (dtp3)?
- Niger ranks 117th out of 194 countries with data for 2025.
- Is diphtheria tetanus toxoid and pertussis third-dose (dtp3) rising or falling in Niger?
- Over the last ten years it is up 3.6%. The long-run trend across the full record is rising.
- Where does this Niger data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).